Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Statins for Venous Event Reduction in Patients With Venous Thromboembolism [Phase 3]
A Phase 3 clinical trial evaluating whether statins can reduce venous thromboembolism events in patients with venous thromboembolism is curr…
-
CLINICAL_TRIALS other · 2026-01-15Clinical Trial Update: A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA [Phase 2]
Phase 2 study comparing SRSD107 with Enoxaparin in adults undergoing total knee arthroplasty to evaluate efficacy and safety for venous thro…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - "MC-MORPHEUS".
This clinical trial update describes the European MORPHEUS project’s effort to combine data from European cohorts related to venous thromboe…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Delivery and Implementation of a Randomised Crossover Trial on Thrombosis [NA]
This clinical trial update describes the delivery and implementation of a randomized crossover trial on thrombosis involving hip fracture an…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients
This clinical trial update reports ongoing recruitment to externally validate the CLOVER score for detecting occult cancer in patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) [Phase 3]
The Conquer-DVT Pilot Trial is a Phase 3 study evaluating whether colchicine can dampen inflammation after deep vein thrombosis; the trial i…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Statins to Prevent Cancer Associated Blood Clots [Phase 4]
Phase 4 trial update examining whether statins can help prevent cancer-associated venous thromboembolism in cancer patients; the study is no…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study [Phase 2]
Prospective Phase II randomized multicenter trial evaluating prolonged anticoagulation for primary prevention of venous thromboembolism in a…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Implementing VTE Prevention in Ambulatory Cancer Care [NA]
This clinical trial update describes efforts to implement venous thromboembolism prevention strategies in ambulatory cancer care.
-
EMA approval · 2025-12-17EMA Authorised: Rivaroxaban Koanaa (rivaroxaban) — Koanaa Healthcare GmbH
The European Medicines Agency authorised Koanaa Healthcare GmbH's rivaroxaban product, Koanaa, for indications including venous thromboembol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
This clinical trial update describes a study investigating how patients' genomic profiles influence thromboembolic risk in locally advanced …
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMWH in Kids for ThromboProphylaxis (CRITICAL-Kids-TP) [Phase 3]
Phase 3 trial evaluating low-molecular-weight heparin for preventing venous thromboembolism in hospitalized, critically ill children; status…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing [Phase 3]
A Phase 3 clinical trial comparing rivaroxaban to low-molecular-weight heparin for prevention of venous thromboembolism in patients with low…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism
This clinical trial update discusses a completed study examining clonal hematopoiesis of indeterminate potential (CHIP) in patients with ven…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women
A clinical trial examining intimate partner violence as a risk factor for venous thromboembolism in women has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk [Phase 3]
Phase 3 clinical trial evaluating the efficacy of intermittent pneumatic compression to reduce venous thromboembolism in ICU patients with h…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Revaluation of Wells' Clinical Prediction Score of Deep Vein Thrombosis (DVT) in Inpatients With Thromboprophylaxis Treatment
This completed clinical trial re-evaluates Wells' prediction score for diagnosing deep vein thrombosis in inpatients receiving thromboprophy…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
This clinical trial is evaluating peripartum anticoagulation management for thromboembolism and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER ) [NA]
Clinical trial update indicating the ETHER study is currently recruiting to evaluate shared decision-making in the management of unprovoked …
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Free DNA and Nucleosome Concentrations in Pathological Pregnancies
A completed clinical trial investigating free DNA and nucleosome concentrations in pathological pregnancies and associated pregnancy-related…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum [NA]
This clinical trial update reports a completed study comparing two low molecular weight heparins as postpartum thromboprophylaxis.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
This update indicates ongoing recruitment for a study at MD Anderson Cancer Center evaluating adherence, health-related quality of life, and…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study [Phase 4]
A Phase 4 pilot study comparing bleeding risk between rivaroxaban and apixaban in venous thromboembolism has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism [Phase 4]
A Phase 4 study compares bleeding risk between rivaroxaban and apixaban for treatment of acute venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty [Phase 2]
A Phase 2 trial evaluating SHR2285 tablets for prevention of venous thrombosis after total knee arthroplasty has been terminated.